Marengo Asia Healthcare, a prominent multi-specialty hospital platform backed by marquee investors including Samara Capital, Havells Family Office, and the Godrej Family Office, has announced a strategic investment of Rs 1.5 billion to expand its presence into Maharashtra and Rajasthan. The move is part of the group’s wider vision to build a pan-India network by strengthening its operations across northern and western India.

Currently operating around 1,500 beds across four hospitals in Delhi NCR and Gujarat, Marengo plans to double its bed capacity to 3,000 within the next 12 months. This will be achieved through a mix of organic growth and targeted acquisitions of standalone hospitals in Maharashtra and Rajasthan, alongside infrastructure upgrades at its existing facilities.

Raajiv Singhal, Founding Member, Group Managing Director and CEO of Marengo Asia Hospitals, stated, “We will consolidate both the North and West clusters. We are adding capacity in Gujarat and evaluating assets in Maharashtra and Rajasthan. This expansion will firmly position us among the top healthcare providers in the country.”

The Rs 1.5 billion investment adds to the group’s cumulative capital deployment, which has now exceeded Rs 15 billion across equity, debt, infrastructure, and acquisitions.

Marengo Asia Healthcare has pursued a rapid growth strategy through acquisitions, including the purchase of W Pratiksha Hospital in early 2023. The group has also consistently upgraded clinical capabilities and infrastructure across its hospitals. Known for its patient-centric care, advanced medical offerings, and academic integration, Marengo continues to establish itself as a next-generation healthcare platform.